07.01.2019 • NewsDede WillamsIndonesialotte

Lotte Breaks Ground on Indonesian Cracker

Lotte Breaks Ground on Indonesian Cracker (c) mmmx/Shutterstock
Lotte Breaks Ground on Indonesian Cracker (c) mmmx/Shutterstock

Lotte Chemical Titan, a subsidiary of the South Korean Lotte group based in Kuala Lumpur, Malaysia, has broken ground for its planned 1 million t/y steam cracker and derivatives project in Cilegon, Banten in Indonesia’s West Java.

Construction work on the more than $3.5 billion project is slated to begin sometime this year or early next year, with completion targeted for 2023. Although naptha will be the principal feedstock, the Korean group said the facility will have “some flexibility” for cracking LPG.

The new cracker will be Lotte’s second in Indonesia. Most of the ethylene produced at Cilegon, Banten will feed a 450,000 t/y polyethylene plant already operating at the site.  Having a cracker at the same site will reduce the plant’s exposure to fluctuating feedstock prices and simplify logistics.

Lotte also operates two crackers in Malaysia.  The only other cracker currently on stream in Indonesia is Chandra Asri's 86,0000 t/y facility, which is in the process of being expanded to 900 000 t/y by 2020.

With the start-up of the new complex, Lotte also plans to start producing PP in Indonesia. The Korean group already operates three PP plants downstream of its two Malaysian crackers.

According to reports, Indonesia is currently only at 36% self-sufficiency in the ethylene chain and is a net importer of ethylene derivatives. When it has reached full run, Lotte’s new cracker is expected to help raise the country’s ethylene self-sufficiency to more than 50%.

 

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.